LB Pharmaceuticals, Inc. Financial Overview
LB Pharmaceuticals, Inc.'s market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; LB Pharmaceuticals, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
